Zika virus infection in pregnancy and infant growth, body composition in the first three months of life: a cohort study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 12 2019
Historique:
received: 20 05 2019
accepted: 27 11 2019
entrez: 18 12 2019
pubmed: 18 12 2019
medline: 5 11 2020
Statut: epublish

Résumé

The implications of Zika Virus exposure in pregnancy for early infant growth remains poorly described. The main goal of this study is to compare the growth, body composition, and feeding modality of infants in the first three months of life by prenatal Zika Virus exposure status. We selected an analytical cohort of 115 infants born without microcephaly, comprising 56 infants with qRT-PCR confirmed exposure to ZIKV during gestation and 59 infants born to women with presumptively no evidence of ZIKV in pregnancy. Infants were evaluated at birth, 1 and 3 months of age in terms of anthropometrics, body composition All the results were adjusted by maternal age, maternal BMI and gestational age. We observe no differences between anthropometric measurements at birth. Mothers in exposed group showed higher BMI. At 1 month and 3 months of age there were differences in mid arm circumference, arm muscle circumference and fat free mass. Weight and length was less in the ZIKV exposed in pregnancy infants and statistically different at 3 month of age. The findings of this investigation provide new evidence that ZIKV exposure in pregnancy may be associated with differences in body composition.

Identifiants

pubmed: 31844129
doi: 10.1038/s41598-019-55598-6
pii: 10.1038/s41598-019-55598-6
pmc: PMC6915782
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19198

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI140718
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129534
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY028318
Pays : United States
Organisme : Wellcome Trust (Wellcome)
ID : 205377/Z/16/Z
Pays : International

Références

J Am Diet Assoc. 2002 Mar;102(3):361-73
pubmed: 11902369
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Rev Paul Pediatr. 2015 Jan-Mar;33(1):3-11
pubmed: 25681074
N Engl J Med. 2018 Mar 15;378(11):985-994
pubmed: 29539287
Malar J. 2016 Feb 16;15:92
pubmed: 26879849
MMWR Morb Mortal Wkly Rep. 2017 Apr 07;66(13):366-373
pubmed: 28384133
Am J Prev Med. 2016 Jun;50(6):761-779
pubmed: 26916261
Lancet. 2016 Jan 30;387(10017):475-90
pubmed: 26869575
BMJ. 2018 Oct 31;363:k4431
pubmed: 30381296
Lancet Infect Dis. 2016 Dec;16(12):1356-1363
pubmed: 27641777
Obesity (Silver Spring). 2011 Sep;19(9):1887-91
pubmed: 21311509
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Am J Clin Nutr. 2004 Apr;79(4):653-60
pubmed: 15051611
BMJ. 2016 Aug 09;354:i3899
pubmed: 27509902
Trop Med Int Health. 2007 May;12(5):594-602
pubmed: 17445127
Int J Environ Res Public Health. 2016 Aug 23;13(9):
pubmed: 27563917
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
Malar J. 2010 Jan 14;9:16
pubmed: 20074331
Acta Paediatr Suppl. 2006 Apr;450:56-65
pubmed: 16817679
Dev Med Child Neurol. 2000 Oct;42(10):674-80
pubmed: 11085295
Early Hum Dev. 2005 Oct;81(10):841-50
pubmed: 16109465
Am J Public Health. 2016 Apr;106(4):598-600
pubmed: 26959258
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Cien Saude Colet. 2010 Mar;15(2):321-7
pubmed: 20414593
BMC Pediatr. 2015 Jun 06;15:66
pubmed: 26048411
Emerg Infect Dis. 2017 Aug;23(8):1253-1259
pubmed: 28604336
Acta Diabetol. 2003 Oct;40 Suppl 1:S55-8
pubmed: 14618434
Am J Clin Nutr. 2017 Aug;106(2):559-567
pubmed: 28659296
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1343-1348
pubmed: 27906905
Lancet Infect Dis. 2018 Mar;18(3):328-336
pubmed: 29242091
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867
pubmed: 30091967
Arch Dis Child Fetal Neonatal Ed. 1997 Sep;77(2):F123-6
pubmed: 9377134

Auteurs

Fernanda Soares (F)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Andrea D Abranches (AD)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Letícia Villela (L)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Sarah Lara (S)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Daniele Araújo (D)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Sylvia Nehab (S)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Leila Silva (L)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Yasmin Amaral (Y)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Saint Clair G Junior (SCG)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Sheila Pone (S)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Ludmila Lobkowicz (L)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Nuria Sanchez Clemente (NS)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Department of Epidemiology, University of São Paulo, São Paulo, Brazil.

Patricia Brasil (P)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Karin Nielsen-Saines (K)

Universidade da California -Pediatric Infectious Disease, UCLA, Los Angeles, California, USA.

Marcos Pone (M)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.

Elizabeth Brickley (E)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Maria Elisabeth Moreira (ME)

Instituto Fernandes Figueira/Instituto Nacional de Infectologia - Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil. bebethiff@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH